Stock Analysts

Qiagen Launches Clinical Insight Bioinformatics Platform

QIAGEN NV QGEN recently launched its Qiagen Clinical Insight (QCI) bioinformatics platform to facilitate clinical testing labs study genomic variants identified through next-generation sequencing (NGS) data. This indicates the company’s efforts to bolster its footprint in the rapidly evolving global bioinformatics market. QCI is a comprehensive, bioinformatics content and software platform that can analyze genomic variants available in published biomedical literature, professional association guidelines, public databases and annotations, drug labels and clinical trials. […]

Stock Analysts

ExxonMobil Investors Reject Climate Change Experts in Board

The majority of investors of the top two oil companies in the U.S. – ExxonMobil Corporation XOM and Chevron Corporation CVX – dismissed the proposal by its minority progressive shareholders to add directors with climate change expertise to their boards. These shareholders also rejected their offer to set targets for greenhouse-gas emissions. […]

Stock Analysts

WPX Energy Sells Marcellus Assets; Focus on Core Business

Oil and gas company WPX Energy Inc. WPX continues to monetize its Marcellus Shale assets, lower its long-term debts and concentrate on its core operations. The company completed its third divestiture of the year, selling a bundle of Marcellus Shale marketing contracts and releasing certain related firm transportation capacity to an undisclosed buyer. […]

Stock Analysts

GlobeImmune-Gilead’s Hepatitis B Drug Fails in Phase II

GlobeImmune, Inc. ’s GBIM shares plummeted 51.3% following the company’s announcement that a randomized, open-label phase II study (0101) on investigational hepatitis B virus (HBV) candidate GS-4774 has failed to meet the primary endpoint. The study compared three doses of GS-4774 (2YU, 10YU or 40YU) in combination with oral antiviral therapy (OAV) versus only antiviral treatment in chronic HBV patients, who were on long-term viral suppression and undergoing an OAV. […]

Stock Analysts

Baxter Faces Moody’s Rating Action on Impending Split

Baxter International Inc. ’s BAX senior unsecured ratings of A3 were recently downgraded to Baa2 by credit rating agency Moody’s MCO , reflecting apprehensions over the upcoming split of the company into two separate entities. However, Moody’s has maintained Prime-2 short term ratings on Baxter and is likely to rate Baxalta Baa2 […]

Stock Analysts

Delta Air Lines (DAL) Adds Five New Routes from Seattle

In sync with its capacity expansion plans, premium U.S. carrier Delta Air Lines DAL plans to initiate flights from the Seattle-Tacoma International Airport to Boston, Orlando, Pasco, Wash and Victoria and British Columbia. Further, the carrier will extend its existing Bozeman, MT, service from the Seattle hub. […]

Stock Analysts

Nokia (NOK) Arm to Acquire Eden Rock Communications

Nokia Corporation ’s NOK wholly-owned subsidiary, Nokia Solutions and Networks (“NSN”), has decided to acquire U.S.-based Eden Rock Communications. However, the financial terms of the transactions have been kept under wraps. The acquisition of Eden Rock Communications, a multivendor self-organizing network (“SON”) will certainly boost Nokia’s network performance during peak hours […]